Amdocs Limited (DOX) Expected to Announce Quarterly Sales of $977.54 Million
Wall Street analysts expect that Amdocs Limited (NASDAQ:DOX) will report sales of $977.54 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Amdocs Limited’s earnings, with the highest sales estimate coming in at $982.57 million and the lowest estimate coming in at $974.94 million. Amdocs Limited reported sales of $940.66 million in the same quarter last year, which suggests a positive year over year growth rate of 3.9%. The business is scheduled to report its next quarterly earnings results after the market closes on Wednesday, November 8th.
According to Zacks, analysts expect that Amdocs Limited will report full year sales of $977.54 million for the current year, with estimates ranging from $3.86 billion to $3.87 billion. For the next financial year, analysts expect that the business will post sales of $4.00 billion per share, with estimates ranging from $3.98 billion to $4.03 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow Amdocs Limited.
Amdocs Limited (NASDAQ:DOX) last announced its earnings results on Wednesday, August 2nd. The technology company reported $1.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.06. The business had revenue of $967.00 million during the quarter, compared to analysts’ expectations of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.75%. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the company posted $0.90 EPS.
Several research analysts have commented on DOX shares. Stifel Nicolaus reissued a “buy” rating and set a $68.00 target price on shares of Amdocs Limited in a research note on Wednesday, June 28th. Zacks Investment Research raised Amdocs Limited from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research note on Friday, August 4th. Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $70.00 target price on shares of Amdocs Limited in a research note on Tuesday, September 5th. Robert W. Baird reissued a “hold” rating and set a $66.00 target price on shares of Amdocs Limited in a research note on Friday, September 1st. Finally, BidaskClub raised Amdocs Limited from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $69.88.
Shares of Amdocs Limited (NASDAQ:DOX) opened at 66.07 on Friday. The firm has a market cap of $9.60 billion, a PE ratio of 23.01 and a beta of 0.53. Amdocs Limited has a 12 month low of $54.91 and a 12 month high of $67.98. The company’s 50 day moving average is $64.61 and its 200-day moving average is $64.04.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 20th. Stockholders of record on Friday, September 29th were paid a $0.22 dividend. This represents a $0.88 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend was Thursday, September 28th. Amdocs Limited’s dividend payout ratio is currently 30.66%.
Institutional investors have recently added to or reduced their stakes in the company. BB&T Investment Services Inc. acquired a new position in shares of Amdocs Limited in the second quarter valued at approximately $118,000. Acrospire Investment Management LLC acquired a new position in shares of Amdocs Limited in the second quarter valued at approximately $155,000. Robecosam AG increased its stake in shares of Amdocs Limited by 37.8% in the second quarter. Robecosam AG now owns 2,550 shares of the technology company’s stock valued at $163,000 after buying an additional 700 shares during the period. Atria Investments LLC acquired a new position in shares of Amdocs Limited in the second quarter valued at approximately $218,000. Finally, HighTower Advisors LLC acquired a new position in shares of Amdocs Limited in the first quarter valued at approximately $220,000. 89.30% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/22/amdocs-limited-dox-expected-to-announce-quarterly-sales-of-977-54-million-2.html.
Amdocs Limited Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.